Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
Research Article
[키워드] acute respiratory syndrome
Affect
Antibody titers
Antiviral
antiviral drug
antiviral efficacy
antiviral therapeutics
approved
candidate
Clinical outcome
Clinical symptoms
clinics
control group
coronavirus
CoV
COVID-19
COVID-19 patients
debate
did not reduce
discrepancy
disease
drug
Drug efficacy
drug treatment
effective vaccine
Effectiveness
Efficacy
exhibited
FDA-approved drug
ferret
ferrets
future therapeutic
group
health care systems
humans
Hydroxychloroquine
hydroxychloroquine sulfate
identify
Immune suppression
Immunosuppressed
Immunosuppression
immunosuppressive
in vivo
Infection
information
Lopinavir-ritonavir
mortalities
nasal
nasal washe
Nasal washes
patients
phosphate-buffered saline
Postinfection
proceed
Prolonged infection
public health
reduced
regulatory agencies
Repurposed drug
required
respiratory tissue
resulting
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 pandemic
Serum Neutralization
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
significantly
significantly lower
specimens
Spread
Stool
suggested
susceptible
tested
therapeutic drug
Therapeutic treatment
treated
Treatment
Trial
trials
viral infection
virus clearance
virus titer
virus titers
were assessed
while
[DOI] 10.1128/mBio.01114-20 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/mBio.01114-20 PMC 바로가기 [Article Type] Research Article